In vitro morphological profiling of T cells predicts clinical response to natalizumab therapy in patients with multiple sclerosis

71

In vitro morphological profiling of T cells predicts clinical response to natalizumab therapy in patients with multiple sclerosis

Tags:

Previous Article

Molecular mechanisms of endometriosis and comorbidities

Predicting if multiple sclerosis medication will be effective for patients

Related Posts

Frazzled/DCC directs spatial progenitor integration ensuring steady-state intestinal turnover

Frazzled/DCC directs spatial progenitor integration ens...

52

Schizophrenia, Dopamine and the Striatum: From Biology to Symptoms

Schizophrenia, Dopamine and the Striatum: From Biology ...

116

Catabolism of extracellular glutathione supplies cysteine to support tumours

Catabolism of extracellular glutathione supplies cystei...

60